Veterinary Diagnostics Markets 2027–2031

Veterinary Diagnostics Markets: Market Forecast, Competitive Landscape, Technology and Channel Outlook, 2027–2031

Global forecasts for veterinary in-vitro diagnostics and imaging by animal, test type, application, setting and product, for 14 countries and regions, with 29 company profiles.

See the Table of Contents. GET the Free Sample of this Report.

Many organizations subscribe to all or some of our reports. You may already have free access to this report. FIND out Here.

Our Take

Veterinary practices are seeing fewer patients but testing each one more, and the tests are getting smarter. Molecular panels, blood-based cancer screening and AI cytology and radiology are moving into the clinic, while outbreaks of screwworm, African swine fever and avian flu keep livestock surveillance busy. The market grows from $13,800 million in 2026 to $20,400 million in 2031, at 8.1% a year, adding $6,600 million.

Market Size 2026: USD $13.8B Market Size 2031: USD $20.4B CAGR: 8.1%

Situation Analysis: what is really happening

• Molecular leads. Molecular testing grows 14.2% a year, from $1,311.0 million to $2,550.0 million, the fastest of any test type.
• Cancer screening arrives. Cancer is the fastest-growing application, at 12.8% a year, from $1,449.0 million to $2,652.0 million; IDEXX added mast cell tumours to its Cancer Dx blood test and slide-free cytology to inVue Dx.
• More testing, fewer visits. US clinic visits fell for a fifth straight year, yet IDEXX raised its 2026 guidance as clinics test more per visit. Veterinary Clinic testing grows 8.9% a year, from $6,141.0 million to $9,384.0 million.
• Outbreaks drive livestock testing. The first US case of New World screwworm in decades was confirmed on 3 June 2026, African swine fever returned to Spain in November 2025 and H5N1 returned to US dairy herds in 2026.
• Imaging goes digital and AI. Imaging grows 8.7% a year, from $2,415.0 million to $3,672.0 million; Zoetis bought the teleradiology company VitalRADS and Antech launched AI dental X-ray reading.
• New owners. Neogen agreed to sell its genomics business to Zoetis for $160 million, and OR Technology and Hallmarq combined into one veterinary imaging group.

Company Analysis: who is positioned, who is exposed

• IDEXX, Zoetis and Antech (Mars Science & Diagnostics): The leaders in in-clinic analysers, rapid tests and reference laboratories.
• Neogen, Thermo Fisher, Innovative Diagnostics (IDvet), Indical, Bionote and Randox: Suppliers of livestock, herd-health and disease-surveillance tests.
• Esaote, Fujifilm, Hallmarq / OR Technology, SignalPET and Vetology: Veterinary imaging systems and AI radiology.
• Volition, Zomedica, Embark and Wisdom Panel: Cancer screening, specialty analysers and consumer genetic tests.
• Mindray Animal Medical, Skyla and Seamaty: Asian challengers in in-clinic chemistry and hematology.
• Covetrus, Vimian, Virbac and Boehringer Ingelheim: Distribution, specialty diagnostics and diagnostic partnerships.

In all, 29 company profiles, each one to two pages with a fact box covering website, headquarters, ownership, revenue, employees and key products.

Questions this report answers

• How large is the veterinary diagnostics market, and which test types and applications grow fastest?
• Can clinics keep growing testing while visits fall?
• How quickly will molecular, cancer screening and AI cytology and radiology spread?
• What do screwworm, African swine fever and avian flu mean for livestock testing?
• Will in-clinic testing take share from reference laboratories?
• How large is each country market, and where is growth fastest?

What's inside

• 285 pages, 23 chapters, 73 tables and 59 figures
• Forecasts for 2027–2031 from a 2026 base year, by animal, test type, application, setting and product, for 14 countries and regions
• Companion animal diagnostics, livestock and herd health, test technologies and a dedicated veterinary imaging chapter
• Settings, channels and business models, regulation and payment, operations, and China, Asia-Pacific and emerging markets
• 10 market-moving developments from 2025 and 2026, SWOT, Porter's Five Forces and strategic recommendations
• 29 company profiles
• Download the Table of Contents (PDF)

Who buys this report

• Animal health and diagnostic companies: plan menus, analysers, imaging and AI strategy.
• Veterinary groups and reference laboratories: plan where to test and which services to build.
• Investors and analysts: model a market reshaped by acquisitions, AI and falling clinic visits.
• Livestock producers and animal health agencies: plan surveillance and outbreak testing capacity.

Use independent research that makes you the expert. Your credit card order sends the report to your inbox instantly. Check all your licensing options, but don't worry: your order is available as a credit if you wish to upgrade.

See the Table of Contents. GET the Free Sample of this Report.

ABOUT THE LEAD AUTHOR

Mr. Greg Powell, B.Sc., M.B.A., is the President of Howe Sound Research. His education includes:

Finance for Senior Executives - Harvard Business School

Market Research - Burke Institute

M.B.A. (Finance and Policy) - University of British Columbia

B.Sc. (Chemistry) - University of British Columbia

He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years.